According to the ESMO guidelines for screening and early detection, early PSA testing (baseline PSA followed by risk-adaptedfollow-up) can be offered to men >50 years, men >45 years with a family history of prostate cancer, African Americans >45 years, and BRCA1/2 carriers >40 years [51]. The gene discussed is BRCA1; the disease is Familial prostate cancer.